IDiyas

For the Inventor, By the Inventor

Langhorne, PA, United States of America

Anthony F Kreft, Iii

USPTO Granted Patents = 29

Average Co-Inventor Count = 4.3

ph-index = 13

Forward Citations = 540(Granted Patents)


Location History:

  • Devon, PA (US) (1984 - 1988)
  • Trooper, PA (US) (1988 - 1992)
  • Langhorne, PA (US) (1991 - 2003)

Company Filing History:

goldMedal28 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1984-2003

Loading Chart...
29 patents (USPTO):Explore Patents
1. 6610734 - Heterocyclic sulfonamide inhibitors of beta amyloid production (2003-08-26),
2. 5830911 - Pyranoindole and tetrahydrocarbazole inhibitors of COX-2 (1998-11-03),
3. 5824699 - Carbazole inhibitors of Cox-2 (1998-10-20),
4. 5776967 - Pyranoindole inhibitors of COX--2 (1998-07-07),
5. 5420289 - Substituted indole-, indene-, pyranoindole- and (1995-05-30),
6. 5364944 - Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid (1994-11-15),
7. 5250693 - Quinolinylmethoxy naphthalenepropionic acid derivatives as (1993-10-05),
8. 5229516 - Substituted indole-, indene-, pyranoindole- and (1993-07-20),
9. 5218124 - Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid (1993-06-08),
10. 5208344 - Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic (1993-05-04),
11. 5159085 - 2-anilino phenylacetic acid derivatives as inhibitors of PLA.sub.2 and (1992-10-27),
12. 5103014 - Certain (1992-04-07),
13. 5084575 - Quinoline substituted naphthalenepropionic acid derivatives as (1992-01-28),
14. 5071988 - Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid (1991-12-10),
15. 5021576 - 2-Anilino phenylacetic acid derivatives (1991-06-04),

Title: Anthony F Kreft, III: A Pioneer in Pharmaceutical Innovations

Introduction: Anthony F Kreft, III, based in Langhorne, PA, has made significant contributions to the pharmaceutical industry, holding an impressive portfolio of 29 patents. His innovative work primarily focuses on the development of compounds that target critical biological mechanisms, showcasing his dedication to advancing medical science.

Latest Patents: Among his latest patents are groundbreaking inventions such as Heterocyclic sulfonamide inhibitors of beta amyloid production and Pyranoindole and tetrahydrocarbazole inhibitors of COX-2. These inventions provide novel compounds of formula I, which display the structure where R is (CH.sub.2).sub.n COOR.sup.4. Such innovations hold promising implications for the treatment of various diseases.

Career Highlights: Throughout his career, Anthony has held key positions in reputable companies, notably at American Home Products Corporation. His expertise and innovative mindset have positioned him as a crucial player in research and development within the pharmaceutical sector.

Collaborations: Anthony has collaborated with talented professionals, including John H Musser and Dennis Michael Kubrak. These partnerships have enriched his work and contributed to the successful development of novel therapeutic compounds.

Conclusion: Anthony F Kreft, III’s career is marked by a commitment to innovation and excellence in pharmaceutical research. His substantial patent portfolio not only highlights his contributions to science but also reflects his dedication to improving healthcare through innovative solutions. As he continues to develop new compounds, the medical community eagerly anticipates the impact of his work on future treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…